The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Genomic Health turns 4Q, full-year 2010 profit

February 9, 2011 5:45 am | by The Associated Press | News | Comments

Clinical diagnostic test developer Genomic Health Inc. turned a fourth-quarter profit as it saw a 14 percent increase in the number of Onco type DX test results delivered.The Redwood City, Calif., company said late Tuesday it earned $1.7 million, or 6 cents per share, in the three months that...

Allied Healthcare 1Q profit hit by UK budget cuts

February 9, 2011 5:45 am | by The Associated Press | News | Comments

British health care staffing company Allied Healthcare International Inc. said Wednesday its profit dropped 36 percent in the fiscal first quarter as the British government reduced its public spending.In the three months ended Dec. 31, Allied said its profit fell to $1.8 million, or 4 cents per...

IBM Business Analytics Helps Sequoia Hospital Cut Mortality Rates in Cardiac Surgery by 50 Percent

February 9, 2011 5:33 am | by IBM | News | Comments

IBM today announced that Sequoia Hospital, based in Redwood City, Calif., has reduced its mortality rate in cardiac surgeries more than 50 percent through the use of IBM predictive analytics software by reducing risk and offering personalized patient care. E-mail this page Save to...


Experts call for greater awareness of the links between diabetes and kidney disease

February 9, 2011 5:33 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Experts are calling for greater awareness of the kidney problems that diabetics can face, after research found that awareness was low among white and South Asian patients. The first time that many patients realized that diabetes could affect their kidneys was when they...


Computational biotech CMD Bioscience finds financing

February 9, 2011 5:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

CMD Bioscience LLC, a computational biotechnology firm in Orange, Conn., has taken in $150,000 of a planned $225,000 mixed offering of equity, debt, warrants and options, according to a regulatory filing.


Q & A: UMass Memorial Deploys Image/EHR Interoperability

February 9, 2011 5:32 am | by Diagnostic Imaging | News | Comments

Can you view medical images directly from your electronic health record? William Corbett, MD, vice president of community practices for UMass Memorial Health Care, discusses the center's decision to implement a system to allow just that, and the benefits they've expereinced so far.


Americord Becomes Only Family Cord Blood Bank Headquartered in New York City to Hold State Cord Blood License

February 9, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 9, 2011 /- Americord Registry , a pioneer in cord blood and placenta stem cell preservation, is proud to announce that it has obtained a provisional human tissue cord blood banking license from the New York State Department of Health, becoming the first private umbilical...


Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels

February 9, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEWTON, Mass., Feb. 9, 2011 /- Rcadia Medical Imaging announced today that it has received FDA 510(k) marketing clearance for an enhanced version of its COR Analyzer® System to assess coronary branch vessels in addition to main coronary arteries in patients with suspected coronary...


Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET

February 9, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Feb. 9, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that it will webcast an investor briefing on Sunday, February 13 from 9 a.m. to 10:30 a.m. Eastern Time.  At the investor briefing, principal investigators from the VEGF Trap-Eye clinical...


PARI Respiratory Launches New Website

February 9, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

MIDLOTHIAN, Va., Feb. 9, 2011 /- Today, PARI Respiratory Equipment launched an updated company website at .  In addition to providing visitors with a beautiful new interface, the website includes easy access to: Continuing Education classes Product instructional videos...

NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials

February 9, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Feb. 9, 2011 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Gregory Glenn, Chief Medical Officer of Novavax, will be presenting safety and immunogenicity data from its pivotal 2009 A/H1N1 virus-like particle (VLP) pandemic...

Federal Register: Medical Device Innovation Initiative; Request for Comments

February 9, 2011 4:31 am | by U.S. Food & Drug Administration | News | Comments

The report proposes potential actions for FDA's CDRH to facilitate the development, assessment, and regulatory review of innovative medical devices.

Federal Register: Medical Device Innovation Initiative; Public Meeting; Request for Comments

February 9, 2011 4:30 am | by U.S. Food & Drug Administration | News | Comments

FDA is seeking input on a number of identified challenges associated with incentivizing innovation, and the proposed solutions. In addition, the Agency requests comments on the Innovation Pathway proposed under the report.

Intuitive Surgical board OKs $400M share buyback

February 9, 2011 3:45 am | by The Associated Press | News | Comments

Intuitive Surgical Inc. said its board has authorized the buyback of up to an additional $298.8 million of the company's outstanding shares, boosting the total available for repurchasing stock to $400 million.The Sunnyvale, Calif., company, which makes the minimally invasive, robotic da Vinci...

NeurogesX to Present at Two February Investor Conferences

February 8, 2011 9:34 pm | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., Feb. 8, 2011 /- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at two upcoming...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.